Find a Clinical Trial

HER2 Negative Breast Cancer

HCRN-BRE20-468 - A Phase II Study of Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR Study)

18+

Learn more

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

18+

Learn more

BCL Study

Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer

18+

Learn more

SPITSS

Salivary Profiling in Infants Treated for Suspected Sepsis: The SPITSS Study

No minimum age

Learn more

Infant Vision Health and Prenatal Drug Exposure

Single-Center Baseline Data on Vision Health in Infants with History of Prenatal Drug Exposure

0-5

Learn more